HS
ABBV icon

Horan Securities’s AbbVie ABBV Stock Holding History

Horan Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$740K Buy
3,989
+147
+4% +$27.3K 0.26% 53
2025
Q1 		$805K Sell
3,842
-41
-1% -$7.97K 0.3% 37
2024
Q4 		$690K Sell
3,883
-112
-3% -$20.6K 0.26% 39
2024
Q3 		$789K Buy
3,995
+141
+4% +$26.3K 0.3% 37
2024
Q2 		$661K Buy
3,854
+8
+0.2% +$1.32K 0.29% 37
2024
Q1 		$700K Buy
3,846
+196
+5% +$33.8K 0.33% 33
2023
Q4 		$566K Buy
3,650
+14
+0.4% +$2.04K 0.28% 35
2023
Q3 		$542K Buy
3,636
+35
+1% +$5.14K 0.29% 32
2023
Q2 		$485K Buy
3,601
+35
+1% +$5.13K 0.21% 55
2023
Q1 		$568K Buy
3,566
+263
+8% +$40.2K 0.29% 33
2022
Q4 		$534K Buy
3,303
+36
+1% +$5.52K 0.3% 31
2022
Q3 		$438K Buy
3,267
+1,709
+110% +$245K 0.27% 34
2022
Q2 		$238K Sell
1,558
-319
-17% -$48.7K 0.14% 76
2022
Q1 		$304K Buy
1,877
+158
+9% +$23K 0.18% 49
2021
Q4 		$233K Buy
+1,719
New +$203K 0.14% 68
2021
Q2 		$137K Buy
1,217
+589
+94% +$66.3K 0.1% 101
2021
Q1 		$68K Buy
628
+504
+406% +$53.9K 0.06% 118
2020
Q4 		$13K Buy
124
+47
+61% +$4.52K 0.01% 227
2020
Q3 		$7K Buy
+77
New +$7.25K 0.01% 234
2018
Q4 		– Sell
-50
Closed -$4K – 218
2018
Q3 		$4K Hold
50
– – ﹤0.01% 175
2018
Q2 		$5K Hold
50
– – ﹤0.01% 162
2018
Q1 		$5K Hold
50
– – ﹤0.01% 148
2017
Q4 		$5K Hold
50
– – ﹤0.01% 149
2017
Q3 		$5K Hold
50
– – ﹤0.01% 135
2017
Q2 		$4K Hold
50
– – ﹤0.01% 144
2017
Q1 		$3K Buy
+50
New +$3.14K ﹤0.01% 150
2016
Q4 		– Sell
-50
Closed -$3K – 32
2016
Q3 		$3K Buy
+50
New +$3.24K ﹤0.01% 125

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Horan Securities's ABBV Position: Q2 2025 in Review

Horan Securities increased its AbbVie (ABBV) stake by 3.8% in Q2 2025, buying an estimated $27.3K and bringing the position to 3,989 shares worth $740K. The position accounts for 0.26% of the portfolio, ranked #53.

Horan Securities first reported a position in ABBV in Q3 2016 and has held it in 27 quarters since. The position peaked at $805K in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Horan Securities held 3,989 shares of AbbVie worth $740K as of Q2 2025.
  • Horan Securities bought 147 AbbVie shares in Q2 2025, an estimated $27.3K.
  • AbbVie made up 0.26% of Horan Securities's portfolio in Q2 2025, its #53 holding.
  • Horan Securities first reported a position in AbbVie in Q3 2016 and has held it in 27 quarters since.
  • Horan Securities's AbbVie position peaked at $805K in Q1 2025.
  • 3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.